IL17A and autoimmune disease: Furthermore, MSCs not only promote a dominant Th2 phenotype but also decrease the proinflammatory cytokines IL-17 and IFN-γ and increase the levels of IL-4, IL-10, and TGF-β in models of autoimmune disease [129, 130].